Oxford BioDynamics Plc (OBD.L) Comparison with companies in other sectors?

Oxford BioDynamics Plc has a share price of 1.96B. You can analyze Oxford BioDynamics Plc (OBD.L) competitors across different market sectors through stock heatmaps.

What are OBD.L's NET and operating margins?

Oxford BioDynamics Plc (OBD.L) operating margin is around -19.61, and net profit margin is approximately -18.19 as of the latest reports.

In what way does OBD.L's earnings per share (EPS) trend reflect its financial momentum?

Oxford BioDynamics Plc (OBD.L) EPS is -0.03 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Oxford BioDynamics Plc is -0.18, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Oxford BioDynamics Plc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Oxford BioDynamics Plc like P/E which is -0.15, P/B which is 0.39, and PEG which is -0.49. Compare them with sector averages to evaluate if the stock is priced fairly.

Oxford BioDynamics Plc

OBD.L•LSE

Healthcare

Biotechnology

£0.55

£0.00(0.00%)

Oxford BioDynamics Plc (OBD.L) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.03

P/E Ratio

-0.18

ROE

-3.87%

Net Margin

-18.19%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$10.77M

Shares OutstandingTotal number of shares issued

$1.96B

Book Value/ShareNet worth per share

$0.01

Revenue/ShareAnnual revenue per share

$0.002

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.03

Net MarginNet income as percentage of revenue

-1818.71%

Operating MarginOperating income as percentage of revenue

-1961.32%

ROEReturn on shareholders' equity

-386.86%

ROAReturn on total assets

-95.53%

ROCEReturn on capital employed

-130.69%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.03

Cash/ShareCash and equivalents per share

$0.009

FCF YieldFree cash flow as percentage of market cap

-98.39%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for OBD.LFinancial Ratios Analysis details for OBD.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for OBD.LSector Benchmarking details for OBD.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Oxford BioDynamics Plc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Oxford BioDynamics Plc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Oxford BioDynamics Plc's unique business strengths and challenges.

Key Financial Metrics for Oxford BioDynamics Plc

For Oxford BioDynamics Plc, essential financial indicators include EPS -0.03, PE -0.18, and ROE -3.87. These key ratios reveal insights into Oxford BioDynamics Plc's profitability, valuation, and operational health. Understanding these metrics enables you to compare Oxford BioDynamics Plc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Oxford BioDynamics Plc

Metrics like Net Margin -1818.71% and ROA -95.53% shed light on how well Oxford BioDynamics Plc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Oxford BioDynamics Plc can sustain its operations and continue growing in the future.

Valuation and Market Position of Oxford BioDynamics Plc

Using ratios such as P/B Ratio 0.39 and PEG Ratio -0.49, investors can assess whether Oxford BioDynamics Plc is appropriately valued based on its financials and growth potential. These figures, combined with Oxford BioDynamics Plc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Oxford BioDynamics Plc

Financial health indicators, such as Debt/Equity Ratio 1.32 and Cash Flow $-0.03, provide a snapshot of Oxford BioDynamics Plc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Oxford BioDynamics Plc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Oxford BioDynamics Plc

Investing in Oxford BioDynamics Plc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Oxford BioDynamics Plc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;